MPN Congress 2022 | The importance of early intervention in young patients with MPNs & the role of interferon therapy
Ghaith Abu-Zeinah
• 3 Nov 2022
Ghaith Abu-Zeinah, MD, Weill Cornell Medicine and the New York Presbyterian Hospital, New York City, NY, comments on excess mortality in young patients with polycythemia vera (PV), emphasizing the importance of early intervention in those patients, and explaining how interferon therapy is a promising treatment option for these patients due to its safety and ability to prolong overall survival (OS). This interview took place at the 14th International Congress on Myeloproliferative Neoplasms (MPN Congress) held in New York City, NY.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
